BioSpace News Archive

Policy

FDA Gives the OK for Florida to Import Drugs from Canada

The state must submit additional information about the drugs it intends to import before the first shipments are sent to the U.S.

January 7, 2024
·
2 min read
·
Tyler Patchen
Business

Calliditas Therapeutics appoints Maria Törnsén as President North America

Calliditas Therapeutics AB, a commercial biopharma company focused on rare diseases announced that Maria Törnsén has been appointed to the position of President North America.

January 7, 2024
·
7 min read
BioMidwest

Akadeum to Present on Award-Winning Microbubble Platform at Biotech Showcase 2024

Akadeum Life Sciences has been selected to present on its revolutionary microbubble platform at this year’s Biotech Showcase, which is being held from January 8-10 in San Francisco.

January 7, 2024
·
2 min read
Biotech Beach

Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance

Exagen Inc., a leading provider of autoimmune testing solutions, announces select preliminary unaudited financial results for the full year ended December 31, 2023, and reaffirms its full-year 2023 financial guidance.

January 7, 2024
·
6 min read
Job Trends

Isomorphic Labs Announces Strategic Multi-Target Research Collaboration With Novartis

Isomorphic Labs announced that it has entered into a strategic research collaboration with Novartis to discover small molecule therapeutics against three undisclosed targets.

January 7, 2024
·
3 min read
BioForest

NanoString’s CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution

NanoString Technologies, Inc. announced the release of the first public dataset of the whole transcriptome obtained at true single-cell resolution on the CosMx™ Spatial Molecular Imager.

January 7, 2024
·
6 min read
Genetown

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

Vertex Pharmaceuticals Incorporated announced multiple program updates ahead of upcoming investor meetings in January, including the company’s scheduled webcast from the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 11:15 a.m. ET/8:15 a.m. PT.

January 7, 2024
·
11 min read
Business

Exact Sciences Announces Preliminary Fourth Quarter 2023 Results

Exact Sciences Corp. announced that the company expects to report revenue between $645.5 million and $647.5 million for the fourth quarter ended December 31, 2023.

January 7, 2024
·
11 min read
Business

Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook

Amicus Therapeutics, a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, provided its preliminary and unaudited 2023 revenue, corporate updates, and full-year 2024 outlook.

January 7, 2024
·
18 min read
Biotech Beach

Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain

Heron Therapeutics, Inc. announced that it has entered into a five-year distributor partnership with CrossLink Life Sciences, LLC to expand the sales network supporting ZYNRELEF® extended-release solution.

January 7, 2024
·
6 min read